Bivalent Omicron BA.1–Adapted BNT162b2 Booster in Adults Older than 55 Years

mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant

(2022) Henning Gruell et al.   NATURE MEDICINE

Neutralization against Omicron SARS-CoV-2 from previous non-Omicron infection

(2022) Jing Zou et al.   Nature Communications

Safety Monitoring of COVID-19 Vaccine Booster Doses Among Adults — United States, September 22, 2021–February 6, 2022

(2022) Anne M. Hause et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Antigenic evolution will lead to new SARS-CoV-2 variants with unpredictable severity

(2022) Peter V. Markov et al.   NATURE REVIEWS MICROBIOLOGY

Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant

(2022) Nick Andrews et al.   NEW ENGLAND JOURNAL OF MEDICINE

Protection by a Fourth Dose of BNT162b2 against Omicron in Israel

(2022) Yinon M. Bar-On et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety and Efficacy of a Third Dose of BNT162b2 Covid-19 Vaccine

(2022) Edson D. Moreira et al.   NEW ENGLAND JOURNAL OF MEDICINE

Short term, relative effectiveness of four doses versus three doses of BNT162b2 vaccine in people aged 60 years and older in Israel: retrospective, test negative, case-control study

(2022) Sivan Gazit et al.   BMJ-British Medical Journal

Durability of BNT162b2 vaccine against hospital and emergency department admissions due to the omicron and delta variants in a large health system in the USA: a test-negative case–control study

(2022) Sara Y Tartof et al.   Lancet Respiratory Medicine

Safety Monitoring of COVID-19 Vaccine Booster Doses Among Persons Aged 12–17 Years — United States, December 9, 2021–February 20, 2022

(2022) Anne M. Hause et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Omicron BA.1 breakthrough infection drives cross-variant neutralization and memory B cell formation against conserved epitopes

(2022) Jasmin Quandt et al.   Science Immunology

Emergence of SARS-CoV-2 Omicron lineages BA.4 and BA.5 in South Africa

(2022) Houriiyah Tegally et al.   NATURE MEDICINE

Neutralization of Omicron BA.1, BA.2, and BA.3 SARS-CoV-2 by 3 doses of BNT162b2 vaccine

(2022) Chaitanya Kurhade et al.   Nature Communications

Neutralization of Omicron sublineages and Deltacron SARS-CoV-2 by three doses of BNT162b2 vaccine or BA.1 infection

(2022) Chaitanya Kurhade et al.   Emerging Microbes & Infections

Safety Monitoring of COVID-19 mRNA Vaccine Second Booster Doses Among Adults Aged ≥50 Years — United States, March 29, 2022–July 10, 2022

(2022) Anne M. Hause et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Antigenic characterization of the SARS-CoV-2 Omicron subvariant BA.2.75

(2022) Qian Wang et al.   Cell Host & Microbe

A Bivalent Omicron-Containing Booster Vaccine against Covid-19

(2022) Spyros Chalkias et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effectiveness and Durability of the BNT162b2 Vaccine against Omicron Sublineages in South Africa

(2022) Shirley Collie et al.   NEW ENGLAND JOURNAL OF MEDICINE

BNT162b vaccines protect rhesus macaques from SARS-CoV-2

(2021) Annette B. Vogel et al.   NATURE

Engineering SARS-CoV-2 using a reverse genetic system

(2021) Xuping Xie et al.   Nature Protocols

Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data

(2021) Eric J Haas et al.   LANCET

Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant

(2021) Jamie Lopez Bernal et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents

(2021) Robert W. Frenck et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months

(2021) Stephen J. Thomas et al.   NEW ENGLAND JOURNAL OF MEDICINE

Sequence analysis of the emerging SARS‐CoV‐2 variant Omicron in South Africa

(2021) Lulan Wang et al.   JOURNAL OF MEDICAL VIROLOGY

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

(2020) Fernando P. Polack et al.   NEW ENGLAND JOURNAL OF MEDICINE

An overview of the regulation of influenza vaccines in the United States

(2016) Jerry P. Weir et al.   Influenza and Other Respiratory Viruses